Bank of New York Mellon’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $579K | Buy |
51,965
+24,060
| +86% | +$268K | ﹤0.01% | 3412 |
|
|
2025
Q1 | $343K | Sell |
27,905
-1,437
| -5% | -$17.7K | ﹤0.01% | 3631 |
|
|
2024
Q4 | $328K | Buy |
29,342
+5,133
| +21% | +$57.4K | ﹤0.01% | 3712 |
|
|
2024
Q3 | $169K | Sell |
24,209
-9,850
| -29% | -$68.7K | ﹤0.01% | 3937 |
|
|
2024
Q2 | $257K | Buy |
+34,059
| New | +$257K | ﹤0.01% | 3868 |
|
|
2022
Q2 | – | Sell |
-17,875
| Closed | -$147K | – | 4667 |
|
|
2022
Q1 | $147K | Hold |
17,875
| – | – | ﹤0.01% | 4328 |
|
|
2021
Q4 | $180K | Buy |
17,875
+395
| +2% | +$3.98K | ﹤0.01% | 4306 |
|
|
2021
Q3 | $277K | Buy |
17,480
+5,981
| +52% | +$94.8K | ﹤0.01% | 4068 |
|
|
2021
Q2 | $274K | Buy |
+11,499
| New | +$274K | ﹤0.01% | 3987 |
|